Scientists have taken a step towards a vaccine for chlamydia following a successful early trial.
A vaccine developed by a British and Danish team was shown to be safe and effective during a randomized controlled trial involving 35 women, according to a study published in medical journal The Lancet Infectious Diseases.Chlamydia is the most common bacterial sexually transmitted infection in the world. There are 131 million new cases every year, according to Imperial College London, with as many as three-quarters showing no symptoms. However it can cause infertility if left untreated.
"It depends a lot on how much funding is available to continue with the vaccine development which will get more expensive at every stage," said Gilbert.While it is scientifically possible for a vaccine to be made available in five years, it is common for vaccines to spend 10 or 20 years in development, she explained.It also depends on the manufacturing capacity of SSI, which produced the vaccine used in the trial.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
A vaccine that may prevent chlamydia is being tested in peopleThe first chlamydia vaccine to be tested in humans shows shown to be safe and may protect against the bacterial infection.
Read more »
MAGIC Shifting Venue, Dates in FebruaryThe early dates mean the trade shows will once again coincide with New York Fashion Week.
Read more »
A$AP Rocky's First Performance Since Swedish Arrest Was Heartfelt, HypedA$AP Rocky's first show in the U.S. since early July went off without a hitch.
Read more »
Chick-fil-A Mac & Cheese: Macaroni and cheese now available nationwide
Read more »
Hong Kong cancels all flights as Beijing says protesters show 'signs of terrorism'Hong Kong’s government canceled all flights departing from the international airport on Monday afternoon, sending police toward the airport as thousands of protesters occupied the terminals in a peaceful sit-in.
Read more »